New innovation hub aims to take a 'moon shot' at cystic fibrosis

18 Apr 2018

Almost 30 years on from the discovery of the genetic defect that causes cystic fibrosis, treatment options are still limited and growing antibiotic resistance presents a grave threat. Now, a team of researchers from across Cambridge, in a major new centre supported by the Cystic Fibrosis Trust, hopes to turn fortunes around.

Read More

Method to predict drug stability could lead to more effective medicines

05 Mar 2018

Researchers from the UK and Denmark have developed a new method to predict the physical stability of drug candidates, which could help with the development of new and more effective medicines for patients. The technology has been licensed to Cambridge spin-out company TeraView, who are developing it for use in the pharmaceutical industry in order to make medicines that are more easily released in the body. 

Read More

In tech we trust?

23 Feb 2018

Fairness, trust and transparency are qualities we usually associate with organisations or individuals. Today, these attributes might also apply to algorithms. As machine learning systems become more complex and pervasive, Cambridge researchers believe it’s time for new thinking about new technology.

Read More

Opinion: What makes the Cambridge cluster special?

13 Nov 2017

Andy Neely is Cambridge’s Pro-Vice-Chancellor for Enterprise and Business Relations, a role which oversees the University’s activities in innovation, commercialisation and entrepreneurship. After six months in the role, he sees an entrepreneurial ecosystem that may appear complex at first – but a deeper examination reveals a combination of knowledge, expertise, support and infrastructure that makes Cambridge one of the most enterprising and entrepreneurial cities in the world. 

Read More

Pages